ETGLX
Price
$54.62
Change
+$0.31 (+0.57%)
Updated
Jul 25 closing price
Net Assets
2.77B
FSMAX
Price
$96.51
Change
+$0.65 (+0.68%)
Updated
Jul 25 closing price
Net Assets
39.17B
Interact to see
Advertisement

ETGLX vs FSMAX

Header iconETGLX vs FSMAX Comparison
Open Charts ETGLX vs FSMAXBanner chart's image
Eventide Gilead N
Price$54.62
Change+$0.31 (+0.57%)
VolumeN/A
Net Assets2.77B
Fidelity Extended Market Index
Price$96.51
Change+$0.65 (+0.68%)
VolumeN/A
Net Assets39.17B
ETGLX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETGLX vs. FSMAX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETGLX is a Buy and FSMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.2B vs. ETGLX (2.77B). FSMAX pays higher dividends than ETGLX: FSMAX (0.47) vs ETGLX (0.00). ETGLX was incepted earlier than FSMAX: ETGLX (17 years) vs FSMAX (14 years). ETGLX (1.36) is less costly to investors than FSMAX (0.04). ETGLX is a more actively managed with annual turnover of: 36.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than ETGLX: FSMAX (0) vs ETGLX (1000). FSMAX annual gain was more profitable for investors over the last year : 14.55 vs. ETGLX (13.05). FSMAX return over 5 years is better than : 60.82 vs. ETGLX (11.18).
ETGLXFSMAXETGLX / FSMAX
Total Expense Ratio1.360.043,886%
Annual Report Gross Expense Ratio1.360.043,886%
Fund Existence17 years14 years-
Gain YTD9.0345.480165%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.77B39.2B7%
Annual Yield % from dividends0.000.47-
Returns for 1 year13.0514.5590%
Returns for 3 years19.0050.7137%
Returns for 5 years11.1860.8218%
Returns for 10 years85.6884.87101%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDVGX17.12N/A
N/A
Sit Dividend Growth I
SVAIX6.36N/A
N/A
Federated Hermes Strategic Value Div IS
FSCDX28.31N/A
N/A
Fidelity Advisor Small Cap A
LYFAX12.30N/A
N/A
AlphaCentric Life Sciences & Hlthcare A
MXETX12.94N/A
N/A
Empower Core Strategies US Eq Inv